Moleculin Announces Annamycin Receives FDA Orphan Drug Designation for Soft Tissue Sarcomas ...Middle East

HOUSTON, Dec. 29, 2020 /PRNewswire/ -- Moleculin Biotech, Inc., (Nasdaq: MBRX) (Moleculin or the Company), a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting highly resistant tumors and viruses, today announced that the US Food and Drug...

Hence then, the article about moleculin announces annamycin receives fda orphan drug designation for soft tissue sarcomas was published today ( Tuesday 29/12/2020 - 04:01 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Moleculin Announces Annamycin Receives FDA Orphan Drug Designation for Soft Tissue Sarcomas )

Also on site :

• Utility poles and trees fall across the area after freezing rain
• Watch the N.H. Liquor & Wine Outlet video that’s lowkey going viral
• Ukrainian drone strikes kill two and injure over 20 in Russia